Human proteinase 3 resistance to inhibition extends to alpha-2 macroglobulin

Koffi N'Guessan1,2, Renata Grzywa3, Seda Seren1,2

  • 1INSERM UMR-1100, CEPR "Centre d'Etude des Pathologies Respiratoires", Tours, France.

The FEBS Journal
|January 30, 2020
PubMed

Insights

Alpha-2-macroglobulin (α2-M) is a poor inhibitor of human proteinase 3 (hPR3). This resistance contributes to hPR3

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Neutrophils contain serine proteases like neutrophil elastase (NE) and proteinase 3 (PR3) that regulate inflammation.
  • Endogenous inhibitors such as alpha-2-macroglobulin (α2-M) control excessive protease activity.
  • Human PR3 (hPR3) is poorly inhibited by some inhibitors, unlike human NE (hNE).

Purpose of the Study:

  • To investigate the inhibitory capacity of α2-M against hPR3.
  • To understand the interaction between α2-M and hPR3 at the molecular level.
  • To elucidate the role of hPR3's resistance to inhibition in inflammatory diseases.

Main Methods:

  • Kinetic and molecular modeling approaches to predict cleavage sites in α2-M's bait region.
  • Mass spectrometry to identify hPR3 cleavage sites in a synthetic α2-M peptide.
  • Assessing the association rate constant (kass) between α2-M and hPR3.

Main Results:

  • α2-M was processed more rapidly by hNE than by hPR3.
  • The association between α2-M and hPR3 was weak (kass ≤ 10^5 M⁻¹s⁻¹).
  • hPR3 showed slow cleavage of the α2-M bait region, indicating poor inhibition.

Conclusions:

  • α2-M is a poor inhibitor of hPR3 due to slow cleavage of its bait region.
  • hPR3's resistance to endogenous inhibitors contributes to its role in tissue injury during chronic inflammation.
  • This resistance also explains hPR3's function as a major autoantigen in granulomatosis with polyangiitis.